Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Packaging
  6. /
  7. HPC Biosciences Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksPackagingHPC Biosciences Ltd

HPC Biosciences Ltd Stock Price Today (NSE: HPBL)

HPC Biosciences Ltd

HPBLPackaging
₹158.10₹4.20 (2.54%)↓
As on 30 Mar 2026, 12:03 pm ISTMarket Closed

Fundamental Score

...

HPC Biosciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

HPC Biosciences Ltd share price today is ₹158.10, down 2.54% on NSE/BSE as of 30 March 2026. HPC Biosciences Ltd (HPBL) is a Small-cap company in the Packaging sector with a market capitalisation of ₹204.16 (Cr). The 52-week high for HPBL share price is ₹215.95 and the 52-week low is ₹88.75. At a P/E ratio of 14.07x, HPBL is currently trading below its industry average P/E of 21.55x. The company has a Return on Equity (ROE) of 17.66% and a debt-to-equity ratio of 2.96.

HPC Biosciences Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-2.54%

Returns & Performance

Good

ROE

17.66%
Poor

ROCE

13.23%
Poor

OPM (5Y)

5.83%

Div Yield

0.52%

HPC Biosciences Ltd Valuation Check

Excellent

P/E Ratio

14.07x
Poor

Industry P/E

21.55x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

204.16 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

164.00%
Excellent

Sales Growth (Q)

68.86%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Balance Sheet Health

Poor

Debt to Equity

2.96x
Average

Int. Coverage

2.73x

Free Cash Flow (5Y)

-171.58 (Cr)

Shareholding

Excellent

Promoter

75.00%
Poor

FII

4.50%
Poor

DII

4.80%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

HPC Biosciences Share Price: A Financial Snapshot and Industry Context

The packaging industry is currently experiencing a shift towards sustainable and biodegradable solutions, driven by both consumer demand and regulatory pressures. This trend highlights a critical area for growth and adaptation. The current HPC Biosciences share price stands at ₹167.0, reflecting a Price-to-Earnings (PE) ratio of 14.07. This initial observation necessitates a deeper dive to assess the company's financial health and potential for sustainable value creation. This analysis is part of an 80-parameter fundamental audit verified by Sweta Mishra.

Comparing HPC Biosciences with its sector peers offers valuable context. While Subam Papers Ltd operates in a related space, differences in management quality, as evidenced by their strategic decisions and capital allocation, are crucial. It would be prudent to compare the consistency of HPC Biosciences' earnings against the more volatile earnings of its peer.

A key strength of HPC Biosciences appears to be its Return on Capital Employed (ROCE) of 13.23%. This indicates the company's efficiency in generating profits from its invested capital. A consistently high ROCE contributes to building a strong economic moat, enabling the company to withstand competitive pressures and maintain profitability. This ability to reinvest profits at a rate exceeding its cost of capital will drive long-term growth.

However, the PE ratio of 14.07 must be considered relative to the industry average and growth prospects. A closer examination of HPC Biosciences' debt levels, cash flow generation, and future expansion plans is essential to determine whether the current valuation is justified. Further investigation into the competitive landscape and the company's market share will also provide a more complete picture of its potential for continued success within the evolving packaging sector. Careful observation of these factors will be essential to assessing future potential.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

HPC Biosciences Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of HPBL across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Strong Return on Equity (17.66%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Attractive Valuation (P/E: 14.07 vs Industry: 21.55)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (164.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (68.86%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Balanced Promoter Holding (75.00%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Elevated Debt Levels (D/E: 2.96)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-171.58 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 9.30%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

HPC Biosciences Ltd Financial Statements

Comprehensive financial data for HPC Biosciences Ltd including income statement, balance sheet and cash flow

About HPBL (HPC Biosciences Ltd)

HPC Biosciences Ltd is a pioneer in the design and manufacture of innovative packaging solutions tailored for the demanding needs of the biopharmaceutical industry. HPBL specialize...s in developing and producing high-performance containers and delivery systems, focusing on maintaining the integrity and efficacy of sensitive biological materials. Their product line encompasses a range of temperature-controlled packaging, including insulated shippers and phase change material (PCM) solutions, ensuring consistent and reliable temperature maintenance throughout the cold chain. Furthermore, HPBL is committed to sustainable practices, exploring biodegradable and recyclable materials to minimize environmental impact. They offer customized packaging solutions designed to meet specific product requirements, including various sizes, formats, and security features, guaranteeing product safety and security during transportation and storage. HPBL's core expertise lies in its ability to combine advanced materials science with precision engineering, producing packaging that exceeds industry standards. Their innovative approach includes integrating real-time monitoring capabilities, allowing for complete visibility of the package's environmental conditions throughout its journey. This integration of technology ensures that clients can track temperature, humidity, and other critical parameters, facilitating informed decision-making and mitigating potential risks. HPBL places a strong emphasis on research and development, consistently pushing the boundaries of packaging technology. They are dedicated to providing reliable and cost-effective solutions that address the evolving challenges faced by the biopharmaceutical sector. HPBL distinguishes itself through its commitment to quality and regulatory compliance, adhering to the most stringent global standards, including those set by the World Health Organization (WHO) and the International Safe Transit Association (ISTA). Their manufacturing processes are meticulously controlled, utilizing state-of-the-art equipment and employing rigorous quality assurance measures. HPBL works in close collaboration with its clients, providing technical support and expert guidance to ensure optimal packaging performance. This collaborative approach extends from initial design concepts to final product delivery, fostering long-term partnerships built on trust and mutual success. HPBL aspires to be the preeminent provider of packaging solutions, empowering the biopharmaceutical industry to deliver life-saving therapies worldwide.

Company Details

Symbol:HPBL
Industry:Packaging
Sector:Packaging
Website:https://hpbl.in

Key Leadership

Mr. Prakash Hiralal Parekh
MD & Executive Director
Jagdeep Singh Rana
Vice President
Mr. Dhrumil Pranavkumar Shah
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date
2025-11-14

HPBL Share Price: Frequently Asked Questions

What is the current share price of HPC Biosciences Ltd (HPBL)?

As of 30 Mar 2026, 12:03 pm IST, HPC Biosciences Ltd share price is ₹158.10. The HPBL stock has a market capitalisation of ₹204.16 (Cr) on NSE/BSE.

Is HPBL share price Overvalued or Undervalued?

HPBL share price is currently trading at a P/E ratio of 14.07x, compared to the industry average of 21.55x. Based on this relative valuation, the HPC Biosciences Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of HPBL share price?

The 52-week high of HPBL share price is ₹215.95 and the 52-week low is ₹88.75. These values are updated daily from NSE/BSE price data.

What factors affect the HPC Biosciences Ltd share price?

Key factors influencing HPBL share price include quarterly earnings growth (Sales Growth: 68.86%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is HPC Biosciences Ltd a good stock for long-term investment?

HPC Biosciences Ltd shows a 5-year Profit Growth of N/A% and an ROE of 17.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 2.96 before investing in HPBL shares.

How does HPC Biosciences Ltd compare with its industry peers?

HPC Biosciences Ltd competes with major peers in the Packaging. Investors should compare HPBL share price P/E of 14.07x and ROE of 17.66% against the industry averages to determine competitive standing.

What is the P/E ratio of HPBL and what does it mean?

HPBL share price has a P/E ratio of 14.07x compared to the industry average of 21.55x. Investors pay ₹14 for every ₹1 of annual earnings.

How is HPBL performing according to Bull Run's analysis?

HPBL has a Bull Run fundamental score of 39.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does HPBL belong to?

HPBL operates in the Packaging industry. This classification helps understand the competitive landscape and sector-specific trends affecting HPC Biosciences Ltd share price.

What is Return on Equity (ROE) and why is it important for HPBL?

HPBL has an ROE of 17.66%, which indicates excellent management efficiency. ROE measures how efficiently HPC Biosciences Ltd generates profits from shareholders capital.

How is HPBL debt-to-equity ratio and what does it indicate?

HPBL has a debt-to-equity ratio of 2.96, which indicates high leverage that increases financial risk.

What is HPBL dividend yield and is it a good dividend stock?

HPBL offers a dividend yield of 0.52%, meaning you receive ₹0.52 annual dividend for every ₹100 invested in HPC Biosciences Ltd shares.

How has HPBL share price grown over the past 5 years?

HPBL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in HPBL and why does it matter?

Promoters hold 75.00% of HPBL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in HPC Biosciences Ltd.

What is HPBL market capitalisation category?

HPBL has a market capitalisation of ₹204 crores, placing it in the Small-cap category.

How volatile is HPBL stock?

HPBL has a beta of N/A. A beta > 1 suggests the HPC Biosciences Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is HPBL operating profit margin trend?

HPBL has a 5-year average Operating Profit Margin (OPM) of 5.83%, indicating the company's operational efficiency.

How is HPBL quarterly performance?

Recent quarterly performance shows HPC Biosciences Ltd YoY Sales Growth of 68.86% and YoY Profit Growth of 164.00%.

What is the institutional holding pattern in HPBL?

HPBL has FII holding of 4.50% and DII holding of 4.80%. Significant institutional holding often suggests professional confidence in the HPC Biosciences Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about HPC Biosciences Ltd

What is the current share price of HPC Biosciences Ltd?

HPC Biosciences Ltd (HPBL) trades at ₹158.10 on NSE and BSE. Market cap ₹204.16 (Cr). Educational data only.

What is the P/E ratio of HPC Biosciences Ltd?

HPC Biosciences Ltd has a P/E of 14.07x vs industry average 21.55x.

What is the Bull Run score for HPC Biosciences Ltd?

HPC Biosciences Ltd has a Bull Run score of 39.9/100 based on 25+ financial parameters.

Does HPC Biosciences Ltd pay dividends?

HPC Biosciences Ltd has a dividend yield of 0.52%. Past dividends don't guarantee future payments.

What is the ROE of HPC Biosciences Ltd?

HPC Biosciences Ltd has ROE of 17.66%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of HPC Biosciences Ltd?

HPC Biosciences Ltd has debt-to-equity of 2.96.

Is HPC Biosciences Ltd a good investment?

Bull Run gives HPC Biosciences Ltd a score of 39.9/100. This is not investment advice — consult a SEBI-registered advisor.